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Significance of arterial spin labeling
perfusion and susceptibility weighted
imaging changes in patients with transient
ischemic attack: a prospective cohort study
Inger Havsteen1* , Lasse Willer2, Christian Ovesen2, Janus Damm Nybing1, Karen Ægidius2, Jacob Marstrand2,
Per Meden2, Sverre Rosenbaum2, Marie Norsker Folke2, Hanne Christensen2 and Anders Christensen1
Abstract
Background: In a prospective cohort of patients with transient ischemic attack (TIA), we investigated usefulness and
feasibility of arterial spin labeling (ASL) perfusion and susceptibility weighted imaging (SWI) alone and in combination
with standard diffusion weighted (DWI) imaging in subacute diagnostic work-up. We investigated rates of ASL and SWI
changes and their potential correlation to lasting infarction 8 weeks after ictus.
Methods: Patients with TIA underwent 3T-MRI including DWI, ASL and SWI within 72 h of symptom onset. We
defined lasting infarction as presence of 8-week MRI T2-fluid attenuated inversion recovery (FLAIR) hyperintensity or
atrophy in the area of initial DWI-lesion.
Results: We included 116 patients. Diffusion and perfusion together identified more patients with ischemia than either
alone (59% vs. 40%, p < 0.0001). The presence of both diffusion and perfusion lesions had the highest rate of 8-week
gliosis scars, 65% (p < 0.0001). In white matter, DWI-restriction was the determinant factor for scar development.
However, in cortical gray matter half of lesions with perfusion deficit left a scar, while lesions without perfusion change
rarely resulted in scars (56% versus 21%, p = 0.03). SWI lesions were rare (6%) and a subset of perfusion lesions.
SWI-lesions with DWI-lesions were all located in cortical gray matter and showed high scar rate.
Conclusions: ASL perfusion increased ischemia detection in patients with TIA, and was most useful in conjunction
with DWI. ASL was fast, robust and useful in a subacute clinical diagnostic setting. SWI had few positive findings and
did not add information.
Trial Registration.: http://www.clinicaltrials.gov. Unique Identifier NCT01531946, prospectively registered February 9,
2012.
Keywords: Transient ischemic attack, Cerebral cortex, Arterial spin labeling
Background
Diagnosing a patient with transient ischemic attack
(TIA) clinically and evaluating the stroke risk hereafter
[1] is a challenge even to experienced stroke neurologists
[2]. The addition of noninvasive arterial spin labeling
(ASL) perfusion imaging to standard TIA-MRI protocol
has been shown to significantly increase the MRI
detection [3] of ischemic findings. Increased reliability, [4]
accessibility and automatization of post-processing have
turned ASL perfusion into a clinically applicable tool [5]
in stroke [6–9] and TIA [3, 10–12]. Focal ASL changes in
cerebral blood flow (CBF), [13, 14] and arterial transit
time, [12, 15, 16] are well described in TIA populations.
[3, 10, 14] Based on ASL, lesions are estimated to occur in
35–56% [3, 17] of patients with TIA. In patients with no
diffusion lesions, contrast-enhanced dynamic susceptibil-
ity contrast (DSC) perfusion imaging detects abnormal-
ities in 16–32% [18, 19] and in 18–46% [3, 17] with both
* Correspondence: Inger.birgitte.havsteen@regionh.dk
1Department of Radiology, Copenhagen University Hospital Bispebjerg,
Bispebjerg Bakke 23, 2400 Copenhagen, NV, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Havsteen et al. BMC Medical Imaging  (2018) 18:24 
https://doi.org/10.1186/s12880-018-0264-6
DSC and ASL. Also, perfusion changes in diffusion nega-
tive patients with clinical TIA are associated with higher
rates of new diffusion weighted imaging (DWI) lesions on
3-day follow-up [20, 21]. It is conceivable that originally
hypoperfused areas may progress to critical ischemia
indicated by new DWI or T2-FLAIR lesions on follow-up
[11, 19]. In addition, perfusion changes might also hold
predictive power towards risk for de-novo future ischemic
events. Consequently, the usefulness of ASL as standard
add-on sequence to DWI in a subacute clinical setting
without off-line post-processing is an open question.
Findings of asymmetric veins based on T2* and
susceptibility weighted imaging (SWI) have also been de-
scribed in stroke populations and correspond approximately
to DSC hypoperfusion areas [22–25] and infarct volume at
72-h follow-up [26]. To our knowledge, SWI and findings in
TIA are not described in literature. As the ischemic event in
TIA is transitory and presumably less profound than in
stroke, SWI may supplement ASL, reflecting venous output
from ischemic tissues and indicating the depth of perfusion
disturbance.
Optimizing the diagnostic yield of the various se-
quences included in the TIA work-up protocol is im-
portant, as since prolonged scan time decreases the
quality of diagnostic evaluation due to the increased in-
cidence of motion artefacts. Motion artefacts increase
with increasing scan time, [27, 28] presence of pathology
[29] and in acute settings [30].
Consequently, we aimed to investigate if standard
DWI plus ASL and SWI compared to DWI alone
increases the neuroradiological detection of ischemia in
patients with TIA in a subacute clinical setting. In
addition, we tested if ASL and SWI added to the predic-
tion of 8-week infarction signs and recurrent cerebrovas-
cular events after TIA.
Methods
We studied a prospective cohort of patients with TIA
admitted February 2012 – December 2014 to our com-
prehensive stroke center. Patients were included after
own written informed consent within 72 h of symptom
onset. The study was approved by the National Com-
mittee of Biomedical Research Ethics (H-1-2011-75,
ClinicalTrials.gov Identifier NCT01531946).
Clinical assessment
Senior consultant stroke neurologists clinically evaluated
patients. Inclusion criteria were admission with acute
focal neurological symptoms believed to be of vascular
origin. Exclusion criteria were MRI contraindications,
non-TIA discharge diagnosis, and severe comorbidity.
We defined TIA as acutely appearing focal neurological
deficit with resolution within 24 h. Resolution was defined
as National Institute of Health Stroke Scale (NIHSS) 0.
Patients were treated in accordance with European and
national guidelines. In this study an ischemic event was
defined based on either radiological signs of ischemia or
clinical judgment in imaging negative patients.
Recurrent ischemic events were defined as new TIA or
stroke diagnosis with clear temporal separation from the
index event. We performed long-term follow-up by na-
tional electronic patient files.
Study procedures
All patients included in this study underwent the base-
line sub-acute MRI during their admission at the stroke
unit. The second MRI was obtained after 8 weeks as an
outpatient procedure.
Imaging
Imaging was performed at 3T (Siemens Magnetom
Verio, Siemens, Erlangen, Germany) with a 32-channel
head coil (Siemens, Erlangen, Germany). The baseline
imaging protocol consisted of ASL, SWI, and DWI and
T2-FLAIR used in our routine TIA protocol. At 8-week
follow-up MRI, we scanned only DWI and T2-FLAIR.
We used Siemens’ 3D background suppressed ep2d
pulsed ASL sequence, TR 2500 ms, TE 11 ms, 192-mm
FOV, FA 90, voxel size 3 × 3 × 6 mm3, TI1 = 700 ms, TI2 =
1800 ms, acceleration factor R = 2, acquisition time
4:22 min:s. Perfusion weighted images, motion corrected
relative CBF and the intrinsic motion correction series
were sent to PACS. The SWI protocol was TR 27 ms, TE
20 ms, 240-mm FOV, FA 15, matrix 243 × 256, 1.0 × 0.9 ×
1.5 mm3 voxel size, 80 slices, acquisition time 5:18 min:s.
ASL and SWI-postprocessing were fully automated as
provided by the vendor.
The DWI was single-shot spin-echo diffusion echo-
planar imaging with 220-mm FOV, 25 4-mm axial slices
with 0-mm gap, b-value 0,1000 s/mm2 along 3 or-
thogonal axes; TR 6600 ms, TE 100 ms, acceleration
factor R = 2, matrix 192 × 192. ADC maps were auto-
matically generated as provided by the vendor.
For T2-FLAIR we used 240-mm FOV, 27 4-mm axial
slices with 0-mm gap, TR 6500 ms, TE 133 ms, TI
2134 ms, acceleration factor R = 2, matrix 256 × 256.
Image analysis
In this study we used only the PACS and no external
software. Between sequences and MRIs performed at
baseline and 8-weeks we identified lesions through their
location, describing their position with two orthogonal
intrathecal diameters. To provide a standardized de-
scription we developed a case report form (CRF) and lit-
erature-based image template with defined scoring
categories. We validated CRF and template on 50 randomly
chosen cases from the cohort with two blinded board-certi-
fied consultant neuroradiologists (AC, IH) reading first
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independently and then jointly establishing final consensus
on the reading tools. Hereafter one reader (IH), blinded to
clinical information except for the referral information, sys-
tematically assessed all baseline and 8-week imaging se-
quences in accordance with the predefined CRF for ASL
perfusion changes, DWI-lesions, SWI asymmetric veins
and missing flow voids and lesion visibility on T2-FLAIR
(Fig. 1). We scored ASL, SWI and DWI images separately
to avoid bias. We categorized lesion location according to
vascular territory and as hemispheric left-, right, bilateral or
infratentorial. For quality control we calculated intraobser-
ver variability for two CRF readings, except for area mea-
surements, at 3 months’ interval in a 10% sample (patients
born 4th, 14th and 24th day in any month) and found sub-
stantial agreement (Cohen’s kappa = 0.80).
As motion artefacts may compromise ASL interpret-
ation, we defined the threshold for permissible motion
as motion in one plane, usually physiological motion in
cranio-caudal direction, and motion presence in less
than 2/3 of the whole brain series’ images. ASL image
quality assessment is detailed in Additional files 1 and 2.
The arterial transit artefact (ATA) depicts areas where
CBF may be normal, but where arterial transit time is in-
creased, and is seen as vivid serpiginous high signal of
labeled blood stagnated in precapillary cortical vessels
[15, 16, 31]. We deemed ASL positive, when at least one
of the following was present: focal low CBF, ATA or
focal hyperperfusion (Fig. 1). SWI asymmetric
prominent veins were defined as regions of multiple
hypointense vessels [25] and dichotomized into presence
and absence. We accepted newfound focal gliosis or at-
rophy on 8-week follow-up MRI as marker for scar tis-
sue after neuronal death and thus critical ischemic depth
[32].
We investigated lesions’ tissue localization stratifying le-
sions after their DWI location into white matter (WM),
cortical gray matter (cGM) and deep gray matter (dGM).
After finalized clinical and radiological data collection,
radiological lesion localization was compared with clin-
ical symptoms for consistency under supervision of a se-
nior neurological consultant (HC).
Statistical analysis
Categorical data were analyzed using Fisher’s exact test.
Differences in continuous and ordinal data were ana-
lyzed using Mann-Whitney U test, and for differences
between proportions we used McNemar-test. Linear rela-
tions between variables and a dichotomous outcome were
tested using bivariate logistic regression. Un-adjusted sur-
vival analysis for recurrent cerebrovascular event was con-
ducted using Kaplan-Meier curves and log-rank test.
Relation between imaging findings and recurrent cerebro-
vascular event was analyzed using Cox Proportional
Hazard Model adjusting for other risk factors. Data were
presented as frequencies, medians with interquartile range
(IQR), odds ratios (OR) or hazard ratios (HR) with 95%
Fig. 1 Subacute diffusion and ASL perfusion lesion and 8-week lasting infarction. Panel a displays a schematic illustration of infarct core with
surrounding penumbra zone of perfusion restriction. Panel b illustrates the larger area of arterial spin labeling lesion with vivid cortical
serpiginous hyperintensities (arterial transit artefact), surrounding a smaller DWI lesion (c). Panel d illustrates the permanent infarction lesion on the
8-week follow-up T2-FLAIR appearing in the same area as the DWI lesion
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confidence intervals (CI) as appropriate. P-values less than
0.05 were considered significant. Statistical analysis was
performed with RStudio (Version 0.97.168) 2012 RStudio
Inc., Boston, MA, USA and SPSS (version 20) statistical
software (IBM Corp, Armonk, New York, USA).
Results
Population
Patient flow is described in (Fig. 2). Median (IQR) age
was 65 (54–71) years, 43% were female, and median
(IQR) ABCD2 was 4 (3–5). Table 1 shows detailed pa-
tient characteristics. The median (IQR) time from ictus
to initial MRI was 38 (24–58) hours. Scans from 4 pa-
tients had unacceptable motion artifacts, and 2 patients
had no ASL done due to a technical error, these were
excluded from the analysis. ASL and SWI with 8-week
follow-up MRI were consequently available for 116 pa-
tients with 148 clinical or radiological events, hereof
were 100 visible ischemic lesions on at least one se-
quence. We differentiated between patients and lesions,
as patients may have multiple lesions in several vascular
territories and not all foci showed perfusion changes.
Among patients 46 (40%) had at least one DWI lesion
and 46 (40%) showed ASL abnormalities, 24 patients
were both DWI and ASL positive (Table 1). Including
both DWI and ASL as diagnostic markers of ischemia
increased ischemia detection from 46 (40%) to 68 (59%)
of 116 patients (p < 0.0001). In the cohort 148 acute clin-
ical or radiological events were detected. Of these, 79
(53%) were DWI positive and 68 (46%) were ASL posi-
tive lesions. Diffusion and perfusion were both positive
in 47 (32%) lesions and 21 lesions (14%) were ASL-
positive and DWI-negative. Diffusion and ASL findings
in patients are detailed in Fig. 3. Among the 68 per-
fusion lesions in 46 patients, ATA was present in 24
(52%, p < 0.0001) patients with perfusion changes and
in relation to 20 (53%, p < 0.0001) hypoperfusion le-
sions. One patient with several lesions showed foci
with hypoperfusion-ATA combination and foci with
Fig. 2 STROBE diagram of patient flow in the study
Table 1 Patient characteristics
All patients 116
Female sex 50 (43%)
Age, median (IQR) 65 (54–71)
Medical history:
Prior stroke 21 (17%)
Prior TIA 10 (9%)
Prior MI 9 (8%)
Atrial fibrillation 12 (10%)
Hypertension 57 (49%)
Diabetes 15 (13%)
Depression 11 (10%)
Current smoking 40 (35%)
Alcohol overuse 10 (9%)
Antiplatelet use 38 (33%)
Warfarin use 0 (0%)
Index stroke:
ABCD2, median (IQR) 4 (3–5)
Duration of symptoms:
< 60 min 56 (48%)
> 60 min 60 (52%)
TOAST etiology:
Small vessels 47 (41%)
Large vessels 26 (22%)
Cardiogenic 18 (16%)
Multiple possible etiologies 25 (22%)
TTS, median (IQR) 38 (24–58)
TTF, median (IQR) 56 (55–60)
Radiological findings:
DWI positive patients 46 (40%)
Lesions, n. 79
ASL positive patients 46 (40%)
Hypoperfusion lesions, n. 38
Hyperperfusion lesions, n. 22
ATA, n. 28
SWI positive patients 5 (4%)
SWI lesions, n. 6
Numbers are frequency (%) unless otherwise indicated. IQR interquartile range,
TIA transient ischemic attack, MI myocardial infarction, NA not applicable,
TTS time to scan, TTF time to follow-up, ATA arterial transit artefact
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hyperperfusion (Fig. 3). There were no distinct lesions
with discernible combinations of ATA and hyperperfusion
or of hypo- and hyperperfusion.
Characteristics of patients with 8-week infarction signs
In patients with DWI-lesions, a subsequent scarring was
observed in 85% at 8 weeks. There was a significant dif-
ference between the different TOAST categories and the
probability of ASL-lesion with small vessel etiology
yielding the lowest probability of ASL-lesion (19%), and
large vessel etiology yielding the highest probability
(65%, p < 0.001). Adjusted for the presence of a DWI le-
sion, large vessel (OR 8.08, 95% CI 2.66–24.52) and mul-
tiple possible etiologies (OR 5.27, 95% CI 1.76–15.75)
yielded a higher probability of ASL-lesion than either
small vessel etiology (reference category) or cardiogenic
etiology (OR 1.97, 95% CI 0.57–6.84). Detailed large ves-
sel findings are shown in Additional file 1: Table S2.
Adding ASL to initial DWI does not increase diagnostic
accuracy of permanent infarction development (Table 2).
During the median (IQR) follow-up period of 1237
(771–1536) days, 17 patients suffered a recurrent
cerebrovascular event. Patients with initial ASL lesion
(Fig. 4) did not show a higher risk of recurrent cerebro-
vascular event (HR 1.87, 95% CI 0.70–4.97) after adjust-
ing for presence of DWI-lesion and ABCD2.
Characteristics of lesions with 8-week infarction signs
A total of 65% of DWI-lesions and 45% of ASL-lesions
subsequently developed a scar on 8-week MRI. We
found the scar-rate to be highest in lesions showing both
diffusion restriction and altered perfusion (65%), how-
ever only slightly, and non-significantly higher than
DWI positive and ASL negative patients (64%). The type
of perfusion finding, e.g. ATA, showed no effect on
the odds for persistent infarction sign development
(Additional file 1: Table S3).
In WM DWI lesions had a high probability of scarring
independent of the presence of perfusion abnormalities
(94% vs. 92%, p = 0.765). In cGM DWI lesions were sig-
nificantly more likely to develop subsequent infarction
after 8 weeks if the lesions was ASL positive (56% vs.
21%, p = 0.029). The median (IQR) size of the DWI le-
sions located in the cGM was not significantly larger
than those located in the WM (28.0 (14.0–51.0) vs. 24.5
(9.0–59.0) mm2; p = 0.463). There was a significant cor-
relation between the size of the DWI lesion and prob-
ability of surrounding ASL lesion (OR 1.02, 95% CI
1.01–1.03 per additional mm2).
We had too few (n = 4) deep gray matter lesions to
conduct a meaningful analysis.
SWI findings
As a subset of patients with ASL abnormalities, we
found 5 patients (with 6 lesions) with SWI abnormal-
ities. In only one patient no corresponding DWI lesion
was found to the ASL and SWI abnormality; this lesion
did not show any scarring at the 8-week MRI. All 5 dif-
fusion positive lesions were located in the cortical gray
matter, and 4 (80%) lesions were followed by 8-week
gliosis scars; this scar rate was higher than the 52%
scar-rate in patients with cGM lesions with ASL abnor-
malities without SWI findings, though not statistically
significant (p = 0.355). SWI abnormalities occurred both
in focal hypoperfusion (2/6), ATA (2/6) and hyperperfu-
sion (3/6).
Discussion
This study showed that using both diffusion and ASL
perfusion imaging identified significantly more patients
as MRI-imaging positive for acute vascular findings than
DWI alone in a subacute clinical setting without external
software. DWI-lesion presence seemed to be the decisive
factor for determining lasting infarct changes after TIA,
especially in white matter. DWI lesions in cortical gray
matter without perfusion change developed few scars,
Fig. 3 Wenn diagram of diffusion and perfusion findings in patients
Table 2 Diagnostic accuracies of DWI and ASL findings for
8-week infarction in patients and lesions
Patients sensitivity specificity PPV NPV accuracy
DWI+ 0.98 0.91 0.85 0.99 0.93
ASL+ 0.58 0.68 0.49 0.75 0.65
DWI+, ASL+ 0.98 0.62 0.57 0.98 0.74
DWI+, ASL- 0.40 0.93 0.76 0.75 0.75
DWI-, ASL+ 0 0.71 0 0.57 0.47
Lesions
DWI+ 0.98 0.71 0.65 0.99 0.80
ASL+ 0.60 0.61 0.46 0.61 0.61
DWI+, ASL+ 0.60 0.83 0.66 0.79 0.75
DWI+, ASL- 0.38 0.88 0.63 0.72 0.72
DWI-, ASL+ 0 0.78 0 0.59 0.51
Havsteen et al. BMC Medical Imaging  (2018) 18:24 Page 5 of 8
while half of lesions with perfusion change left a scar.
SWI did not add to detection of ischemia in TIA, but
may indicate profound perfusion disturbance.
Our study has a high frequency of lesions, most likely be-
cause of inclusion of well-defined patients and subsequent
exclusion of patients with other final diagnoses than TIA.
This hampers generalizability to less selected emergency
room patients concerning lesion frequency, however not re-
garding the natural MRI history of ischemic lesions after
TIA. The rates of DWI lesions are reported to vary between
25 and 50% [3, 17, 18, 33–36] and to be halved in popula-
tions with high stroke awareness and easy-access high-vol-
ume TIA clinics [37].
Other potential limitations are: Motion artifacts in-
crease with scan time [27, 28, 38] and may compromise
perfusion parameter estimates [5]. We had too few deep
gray matter lesions and SWI positives for meaningful
subgroup analysis. Our SWI positive lesions were a sub-
set of perfusion positives that with concomitant DWI
lesions showed high scarring rate. This may indicate that
visible venous congestion serves as marker for focal is-
chemic depth, exploration would need more data.
We confirmed that the combination of diffusion and
ASL perfusion identifies significantly more lesions than
either sequence alone in TIA, [3, 14] from 40% up to
nearly 60% of TIA patients in our subacute clinical set-
ting. Roughly half of white matter lesions showed perfu-
sion change compared to three quarters of cortical
lesions: This presumably reflects the local vascularity
with rich collaterals cortically and fewer in deeper tissue,
relying on perforants, [39–41] and the longer and more
heterogeneous transit times of white matter [42, 43] de-
creasing ASL’s sensitivity to focal changes. This also ex-
plains the lower probability of ASL changes in patients with
small vessel etiology. Larger cortical lesions may also show
signs of venous congestion, their frequency in our TIA
population was scarce compared to stroke populations [25].
In our small population positive image findings did
not influence the post-TIA stroke risk, nor did anyone
among the 22 patients with perfusion deficits only de-
velop infarction signs at 8-week follow-up, perhaps due
to small sample size.
In our clinical setting without external post-processing
software the speed and accessibility of diffusion and ASL
perfusion imaging enabled us to increase ischemia detec-
tion in comparison to diffusion imaging alone. This may
aid in identification of high-risk patients with TIA with
imaging abnormalities. Our standard vendor pulsed ASL
sequence proved robust and identified perfusion changes
larger than diffusion lesions and showed perfusion
change in DWI-negative patients. ATA often bordered
hypoperfused areas and served as an easily identifiable
pointer useful in the clinical situation, and we deemed it
worth the extra scan time.
Conclusions
Ischemia detection is improved by adding ASL to the
TIA protocol, and the standard sequence proved feasible
and robust in a clinical setting. SWI did not add critical
information in subacute diagnostic work-up for TIA.
Localization and underlying local vascularity seem to be
key factors in the morphologic development of ischemia
lesion depth and long-term traces.
Additional files
Additional file 1: Supplementary methodology. Motion artefact assessment.
Supplemental results. Table S1. Combinations of number of planes and
images affected by subject motion for n= 116 patients. Table S2. Large vessel
A B
Fig. 4 Event recurrence stratified by lesion characteristics. Two Kaplan-Meier curves showing recurrent cerebrovascular event in the TIA population
stratified by MRI-sequence positivity. Panel a shows that patients with ASL perfusion lesions do not experience a higher risk of recurrent cerebrovascular
events compared to TIA patients displaying no perfusion lesion. Panel b: shows that radiological evidence of acute ischemia (either restricted perfusion or
diffusion) does not identify patients in higher risk of recurrent event
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findings for patients (n= 116) stratified after most likely etiology after full
radiological and clinical workup. Table S3. Risk of persistent infarction signs for
DWI lesions and perfusion findings. (DOCX 20 kb)
Additional file 2: Figure S1. ASL interpretability and artefact
description for 116 patients. Top 4 rows compare ASL PWI and relCBF
images. Bottom row shows ring artefact frequency. GW = gray-white
matter discrimination. (PDF 4 kb)
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